ProfileGDS4718 / 227865_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 84% 81% 80% 77% 75% 74% 80% 82% 79% 79% 82% 79% 71% 72% 78% 81% 81% 72% 82% 80% 81% 79% 81% 77% 78% 82% 78% 80% 77% 86% 75% 86% 77% 75% 80% 75% 83% 82% 82% 79% 79% 74% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0374872
GSM549102patient 115, normal, homogenized [OPG study]8.3106284
GSM549104patient 119, normal, homogenized [OPG study]8.0709181
GSM549108patient 138, normal, homogenized [OPG study]7.7679180
GSM549119patient 077, normal, homogenized [OPG study]7.4978377
GSM549133patient 032, cancer, homogenized [OPG study]7.4656675
GSM549139patient 042, cancer, homogenized [OPG study]7.3084874
GSM549099patient 107, normal, homogenized [OPG study]7.7912580
GSM549109patient 139, normal, homogenized [OPG study]7.9752482
GSM549110patient 046, normal, homogenized [OPG study]7.6855279
GSM549114patient 063, normal, homogenized [OPG study]7.8008879
GSM549122patient 082, normal, homogenized [OPG study]8.0770682
GSM549134patient 033, cancer, homogenized [OPG study]7.7716479
GSM549136patient 036, cancer, homogenized [OPG study]6.9785371
GSM549140patient 044, cancer, homogenized [OPG study]7.1104172
GSM549111patient 047, normal, homogenized [OPG study]7.6277678
GSM549113patient 057, normal, homogenized [OPG study]8.0487381
GSM549132patient 031, cancer, homogenized [OPG study]7.9519181
GSM549137patient 038, cancer, homogenized [OPG study]7.0770572
GSM549142patient 047, cancer, homogenized [OPG study]7.8398682
GSM549100patient 110, normal, homogenized [OPG study]7.7394580
GSM549107patient 135, normal, homogenized [OPG study]8.0296781
GSM549115patient 068, normal, homogenized [OPG study]7.8391179
GSM549116patient 072, normal, homogenized [OPG study]8.0570581
GSM549120patient 078, normal, homogenized [OPG study]7.5047777
GSM549131patient 030, cancer, homogenized [OPG study]7.745578
GSM549118patient 074, normal, homogenized [OPG study]8.1271682
GSM549129patient 027, cancer, homogenized [OPG study]7.6695178
GSM549123patient 088, normal, homogenized [OPG study]7.899180
GSM549124patient 006, cancer, homogenized [OPG study]7.4603977
GSM549126patient 015, cancer, homogenized [OPG study]8.5615786
GSM549128patient 025, cancer, homogenized [OPG study]7.4388975
GSM549103patient 117, normal, homogenized [OPG study]8.4228486
GSM549117patient 073, normal, homogenized [OPG study]7.4701277
GSM549138patient 041, cancer, homogenized [OPG study]7.41875
GSM549141patient 045, cancer, homogenized [OPG study]7.9485580
GSM549130patient 028, cancer, homogenized [OPG study]7.3390775
GSM549101patient 111, normal, homogenized [OPG study]8.1747483
GSM549105patient 128, normal, homogenized [OPG study]8.0091682
GSM549106patient 134, normal, homogenized [OPG study]8.2667982
GSM549112patient 048, normal, homogenized [OPG study]7.7793379
GSM549125patient 011, cancer, homogenized [OPG study]7.7327179
GSM549127patient 024, cancer, homogenized [OPG study]7.3353374
GSM549135patient 035, cancer, homogenized [OPG study]7.0404471